@article{72b363f2939949898afcc4e2bafbae4a,
title = "Angiogenesis Inhibitors for Head and Neck Squamous Cell Carcinoma Treatment: Is There Still Hope?",
keywords = "anti-angiogenesis, head and neck cancer, therapy, endostatin, bevacizumab, PHASE-II-TRIAL, ADVANCED NASOPHARYNGEAL CARCINOMA, RECOMBINANT HUMAN ENDOSTATIN, AND/OR METASTATIC HEAD, LOCALLY ADVANCED HEAD, RADIATION-THERAPY, CONCURRENT CHEMORADIATION, HEPATOCELLULAR-CARCINOMA, TARGETING ANGIOGENESIS, TUMOR ANGIOGENESIS, 3122 Cancers",
author = "Aini Hyyti{\"a}inen and Wafa Wahbi and Otto V{\"a}yrynen and Kauko Saarilahti and Peeter Karihtala and Tuula Salo and Ahmed Al-Samadi",
year = "2021",
month = jun,
day = "14",
doi = "10.3389/fonc.2021.683570",
language = "English",
volume = "11",
journal = "Frontiers in oncology ",
issn = "2234-943X",
publisher = "Frontiers Media",
}